Straits Times Index
3,269.27 -32.69 (-0.99%) Nikkei
28,546.98 +727.65 (+2.62%) Hang Seng
20,175.62 +93.19 (+0.46%) FTSE 100
7,500.89 +34.98 (+0.47%) BTC-USD
24,502.36 +648.65 (+2.72%) CMC Crypto 200
574.64 +3.36 (+0.59%)
Laboratory Corporation of America Holdings (LH)
After hours:
| Previous close | 258.74 |
| Open | 258.92 |
| Bid | 252.88 x 800 |
| Ask | 263.00 x 900 |
| Day's range | 256.95 - 259.92 |
| 52-week range | 212.40 - 317.17 |
| Volume | |
| Avg. volume | 754,803 |
| Market cap | 23.452B |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | 12.40 |
| EPS (TTM) | 20.92 |
| Earnings date | 26 Oct 2022 - 31 Oct 2022 |
| Forward dividend & yield | 2.88 (1.11%) |
| Ex-dividend date | 17 Aug 2022 |
| 1y target est | 303.69 |
- Motley Fool
Laboratory Corporation of America (LH) Q2 2022 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Labcorp Second quarter 2022 Earnings Call. With me today are Adam Schechter, chairman and chief executive officer; and Glenn Eisenberg, executive vice president and chief financial officer. This morning, in the investor relations section of our website at www.labcorp.com, we posted both a press release and an investor relations presentation with additional information on our business and operations, which includes a reconciliation of the non-GAAP financial measures to the GAAP financial measures discussed during today's call, as well as a presentation on additional information on the spin-off of the clinical development business.
- Zacks
LabCorp (LH) Q2 Earnings Top Estimates, Raises '22 EPS View
LabCorp (LH) posts better-than-expected earnings in the second quarter and demonstrates continued strength in the organic Base Business.
- Zacks
LabCorp (LH) Q2 Earnings Beat Estimates
LabCorp (LH) delivered earnings and revenue surprises of 6.21% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
